ANALYSIS: Medicinal cannabis has been legal since 2016 and while more than one million Australians have been prescribed cannabis products, the industry continues to struggle for profitability.
ANALYSIS: Paul Volcker’s legendary attack on inflation led to deepest recession.
ANALYSIS: A turbulent journey, but a better destination.
ANALYSIS: Despite spending $24b on health this year, sector still under severe strain.
Under duress the supermarket duopoly is transforming – but aims to retain its invisible hand.
Francis Fukuyama argues the case against enemies on left and right.
ANALYSIS: NZ Funds talk up spring around the corner, despite crypto market’s carnage.
ANALYSIS: Fletcher Building is taking the heat for stockouts but it's a creature of a special environment.
ANALYSIS: The Government is rushing through legislation on political finance for no apparent reason.
ANALYSIS: Rocket Lab's share price has crashed since listing, but there are reasons for optimism.